PlaqueTec and Babraham Institute partner for treatment of coronary heart disease
CAD is responsible for around 68,000 deaths per year in the UK
Read More
Tag: Liquid Biopsy System
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
